Skip to main content

Table 5 Distribution of resistance genes

From: Antimicrobial susceptibility and resistance mechanisms of methicillin resistant Staphylococcus aureusisolated from 12 Hospitals in Turkey

Number of Resistant isolates (%) Antibiotics
Erythro* Linco Tetra Genta Cipro Line F. Acid Vanco Kana
225 (56.7) 168 (42.3) 350 (88.2) 358 (90.2) 366 (92.2) 0 (0) 32 (8.1) 0 (0) 363 (91.4)
Gene (%) ermA (21.3) ermA (5.4) tetM (90) aac-aph (93) ND** ND ND ND ND
  ermB (0) ermB (0) tetK (2.9)       
  ermC (8.9) ermC (10.1)        
  ermA-B (0.4) ermA-B (0.6)        
  ermB-C (0.4) ermB-C (0.6)        
  ermA-C (56.9) ermA-C (73.8)        
  ermA-B-C (0.9) ermA-B-C ( 1.2)        
  msrA (0.9) msrA (0)        
  msrA,ermA (0.9) msrA,ermA (0)        
  msrA, ermB (0.4) msrA, ermB (0)        
  msrA,ermC (0.4) msrA,ermC (0.6)        
linA, msrA (0.6) msrA,ermA-C (1.8) msrA,ermA-C (2.4)        
Unknown (6.6) Unknown (4.7) Unknown (7.1) Unknown (7)      
  1. *Erythro, Erythromycin; Linco, Lincomycin; Tetra, Tetracycline; Genta, Gentamycin; Cipro, Ciprofloxacin; Line, Linezolid; F. Acid, Fusidic Acid; Vanco, Vancomycin; Kana, Kanamycin.
  2. **ND; Not Determined.